Dyne Therapeutics (DYN) EPS (Basic) (2019 - 2026)
Dyne Therapeutics (DYN) posted quarterly EPS (Basic) of -$1.59 for Q2 2026, down 65.56% year-over-year from -$4.61 in Q2 2025, and down 49.45% quarter-over-quarter from -$1.06 in Q1 2026.
Powered by 
Analysis
Dyne Therapeutics (DYN) EPS (Basic) (2019 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has reported EPS (Basic) for 8 consecutive years, with -$1.59 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) fell 65.56% year-over-year to -$1.59; the TTM figure through Jun 2026 stood at -$3.97 (down 5.52% YoY), while the FY2025 annual figure was -$6.68, down 3.79% from the prior year.
- EPS (Basic) fell to -$1.59 in Q2 2026 per DYN's latest filing, from -$1.06 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.76 in Q3 2025 and bottomed at -$3.55 in Q4 2023.
- Historically, EPS (Basic) has averaged -$1.57 across 5 years, with a median of -$1.26 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 187.13% — and 2024, when it jumped 71.7%.
- Dyne Therapeutics' EPS (Basic) stood at -$2.93 in 2022, then slipped by 20.96% to -$3.55 in 2023, then surged by 71.7% to -$1.0 in 2024, then rose by 13.89% to -$0.86 in 2025, then sank by 83.62% to -$1.59 in 2026.
- Business Quant data shows DYN's EPS (Basic) at -$1.59 in Q2 2026, -$1.06 in Q1 2026, and -$0.86 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Dyne Therapeutics | 4.01 Bn | 4.01 Bn | - | -1.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 |
| Mar 31, 2026 | -0.76 |
| Dec 31, 2025 | -0.84 |
| Sep 30, 2025 | -0.76 |
| Jun 30, 2025 | -0.96 |
| Mar 31, 2025 | -1.11 |
| Dec 31, 2024 | -0.95 |
| Sep 30, 2024 | -0.95 |
| Jun 30, 2024 | -0.78 |
| Mar 31, 2024 | -0.85 |
| Dec 31, 2023 | -1.10 |
| Sep 30, 2023 | -0.98 |
| Jun 30, 2023 | -1.11 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -0.75 |
| Sep 30, 2022 | -0.80 |
| Jun 30, 2022 | -1.03 |
| Mar 31, 2022 | -0.71 |
| Dec 31, 2021 | -1.02 |
| Sep 30, 2021 | -0.83 |